MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    High intensity exercise improves Sleep EEG Delta Power in Parkinson’s Disease

    A. Memon, K. Wood, A. Joop, R. Memon, J. Pilkington, C. Catiul, M. Bamman, S. Miocinovic, A. Amara (Birmingham, USA)

    Objective: This novel study tests the hypothesis that 16 weeks of high-intensity exercise rehabilitation combining resistance training plus body-weight interval training, compared with a sleep…
  • MDS Virtual Congress 2021

    Locus coeruleus volume is reduced in Parkinson disease-related orthostatic hypotension.

    P. Beach, N. Kurra, K. Hwang, J. Langley, X. Hu, D. Huddleston (Atlanta, USA)

    Objective: To test whether structural pathology of the locus coeruleus (LC) is associated with orthostatic hypotension (OH) in Parkinson disease (PD). Background: OH is an…
  • MDS Virtual Congress 2021

    Intermittent theta burst stimulation over primary motor cortex ameliorates physical fatigue in Parkinson’s disease patients

    J. Gómez-Feria, S. Blanco-Trejo, S. Jesús, L. Chirosa-Rios, I. Chirosa-Rios, JF. Martín-Rodríguez, P. Mir (Sevilla, Spain)

    Objective: To evaluate the effect of a single intermittent theta burst stimulation (iTBS) session on objective markers of physical fatigue of fatigue in patients with…
  • MDS Virtual Congress 2021

    Behavioral effects of stimulated dopamine release and D2-like receptor displacement in Parkinson’s patients with impulse control disorder

    S. Lee, M. Aumann, A. Song, K. Hay, P. Diaz, Y. Yan, H. Kang, D. Claassen (Nashville, USA)

    Objective: To evaluate behavioral effects of stimulated dopamine (DA) release in Parkinson’s disease (PD) by assessing D2/3 receptor (DA-R) displacement on PET imaging Background: Previous…
  • MDS Virtual Congress 2021

    Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

    M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)

    Objective: To develop a mobile application for assessing the likelihood of developing depression in patients with Parkinson's disease (PwPD), taking into account the number of…
  • MDS Virtual Congress 2021

    The Impact of Back and Neck Pain in Parkinson’s Disease: The PD-PAIN Study

    D. Shpiner, T. Rundek, H. Li, I. Haq, C. Luca, J. Margolesky, H. Moore, C. Singer (Miami, USA)

    Objective: To determine the prevalence of back and neck pain (BNP) in Parkinson’s Disease (PD) patients and the proportion of patients seeking invasive treatments for…
  • MDS Virtual Congress 2021

    A corneal nerve density possible progression biomarker in Parkinson’s disease (PD) patients: pilot study

    S. Yaisawang, J. Sringean, N. Kasetsuwan, R. Bhiyasiri (Bangkok, Thailand)

    Objective: To evaluate corneal sub-basal nerve plexus density in PD compared to age-matched healthy subjects using confocal microscopy Background: Cornea is the most densely innervated…
  • MDS Virtual Congress 2021

    HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson’s disease and type 2 diabetes.

    B. Huxford, T. Haque, A. Joseph, C. Simonet, D. Gallagher, C. Budu, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to investigate the relationship between glycated haemoglobin (HbA1c) levels in blood and clinical outcomes (MDS-UPDRS III, MDS-UPDRS IV,…
  • MDS Virtual Congress 2021

    Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study

    P. Zhang, P. Huang, Y. Qian, X. Yang, Y. He, J. Du, G. Li, S. Cui, S. Xu, J. Liu, Y. Lin, Y. Fu, G. He, Z. Zhang, Q. Xiao, S. Chen (Shanghai, China)

    Objective: To investigate the difference in the gut microbiota between drug-naïve and medicated PD patients and focus on the association between gut microbiota and anti-PD medications. Background:…
  • MDS Virtual Congress 2021

    Characterization of a mouse model of PDE10A-related autosomal-dominant movement disorder.

    N. Marotta, N. Mencacci, M. Pereira Luppi, R. Awatramani, D. Krainc (Chicago, USA)

    Objective: To characterize a newly generated mouse model of the movement disorder caused by PDE10A pathogenic mutation F300L. Background: Phosphodiesterase 10A (PDE10A) is a striatal…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley